Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Dunstan

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Statistics in Medicine|June 1, 1991
Maximum likelihood techniques applied to method comparison studiesA B Nix, F D Dunstan
Annals of Clinical Biochemistry|February 17, 1998
Screening for Down's syndrome: the effect of test date on the detection rateF D Dunstan, A B Nix
Statistics in Medicine|June 1, 1991
Estimation of the mean and standard deviation using order statisticsF D Dunstan, A B Nix
Statistics in Medicine|November 1, 1991
The detection of artefacts in EEG seriesF D Dunstan, R W Marshall
British Journal of Obstetrics and Gynaecology|February 1, 1997
The impact of maternal age on the cost effectiveness of Down's syndrome screeningF D Dunstan, A B Nix
Schizophrenia Bulletin|December 16, 1998
Changes in the risk of schizophrenia in Scotland: is there an environmental factor?A H Al Mousawi, F D Dunstan
Medical and Pediatric Oncology|April 29, 1999
Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemiaV Clarke, F D Dunstan, D K Webb
Annals of Clinical Biochemistry|January 1, 1997
The effects of gestation dating on the calculation of patient-specific risks in Down's syndrome screening: multivariate caseJ C Bishop, F D Dunstan, A B Nix
Annals of Clinical Biochemistry|March 29, 2000
Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's syndrome screeningK L Williams, B A Nix, F D Dunstan
Early Human Development|December 30, 1996
Detection rates and false positive rates for Down syndrome screening: how precisely can they be estimated?J C Gray, F D Dunstan, A B Nix
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Statistics in Medicine|June 1, 1991
Maximum likelihood techniques applied to method comparison studiesA B Nix, F D Dunstan
Annals of Clinical Biochemistry|February 17, 1998
Screening for Down's syndrome: the effect of test date on the detection rateF D Dunstan, A B Nix
Statistics in Medicine|June 1, 1991
Estimation of the mean and standard deviation using order statisticsF D Dunstan, A B Nix
Statistics in Medicine|November 1, 1991
The detection of artefacts in EEG seriesF D Dunstan, R W Marshall
British Journal of Obstetrics and Gynaecology|February 1, 1997
The impact of maternal age on the cost effectiveness of Down's syndrome screeningF D Dunstan, A B Nix
Schizophrenia Bulletin|December 16, 1998
Changes in the risk of schizophrenia in Scotland: is there an environmental factor?A H Al Mousawi, F D Dunstan
Medical and Pediatric Oncology|April 29, 1999
Granulocyte colony-stimulating factor ameliorates toxicity of intensification chemotherapy for acute lymphoblastic leukemiaV Clarke, F D Dunstan, D K Webb
Annals of Clinical Biochemistry|January 1, 1997
The effects of gestation dating on the calculation of patient-specific risks in Down's syndrome screening: multivariate caseJ C Bishop, F D Dunstan, A B Nix
Annals of Clinical Biochemistry|March 29, 2000
Effect of screening algorithm, parameter values and median smoothing on patient-specific risk estimates for Down's syndrome screeningK L Williams, B A Nix, F D Dunstan
Early Human Development|December 30, 1996
Detection rates and false positive rates for Down syndrome screening: how precisely can they be estimated?J C Gray, F D Dunstan, A B Nix
Pageof 4